Literatura académica sobre el tema "Multidrug nanoparticles"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Multidrug nanoparticles".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Multidrug nanoparticles"
& MAHMOOD, HAMID. "THE SYNERGISTIC EFFECT OF GOLD NANOPARTICLE LOADED WITH CEFTAZIDIUM ANTIBIOTIC AGAINST MULTIDRUG ERSISTANCE PSEUDOMONAS AERUGINOSA". IRAQI JOURNAL OF AGRICULTURAL SCIENCES 52, n.º 4 (22 de agosto de 2021): 828–35. http://dx.doi.org/10.36103/ijas.v52i4.1391.
Texto completoHuq, Md Amdadul, Md Ashrafudoulla, Md Anowar Khasru Parvez, Sri Renukadevi Balusamy, Md Mizanur Rahman, Ji Hyung Kim y Shahina Akter. "Chitosan-Coated Polymeric Silver and Gold Nanoparticles: Biosynthesis, Characterization and Potential Antibacterial Applications: A Review". Polymers 14, n.º 23 (4 de diciembre de 2022): 5302. http://dx.doi.org/10.3390/polym14235302.
Texto completoShair Mohammad, Imran, Birendra Chaurasiya, Xuan Yang, Chuchu Lin, Hehui Rong y Wei He. "Homotype-Targeted Biogenic Nanoparticles to Kill Multidrug-Resistant Cancer Cells". Pharmaceutics 12, n.º 10 (9 de octubre de 2020): 950. http://dx.doi.org/10.3390/pharmaceutics12100950.
Texto completoAbd. Alaameri, Sally K., Huda S. A. Al-Hayanni y Labeeb A. K. Al-Zubaidi. "Antibacterial and anti-biofilm properties of biosynthesized Silver nanoparticles using Sumac (Rhus coriaria L.) extracts against some pathogenic bacteria". Sumer 3 8, CSS 3 (15 de octubre de 2023): 1–15. http://dx.doi.org/10.21931/rb/css/2023.08.03.53.
Texto completoRoszczenko, Piotr, Olga Klaudia Szewczyk, Robert Czarnomysy, Krzysztof Bielawski y Anna Bielawska. "Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles". Pharmaceutics 14, n.º 11 (25 de octubre de 2022): 2286. http://dx.doi.org/10.3390/pharmaceutics14112286.
Texto completoShrivastava, A., RK Singh, PK Tyagi y D. Gore. "Synthesis of Zinc Oxide, Titanium Dioxide and Magnesium Dioxide Nanoparticles and Their Prospective in Pharmaceutical and Biotechnological Applications". Journal of Biomedical Research & Environmental Sciences 2, n.º 1 (11 de enero de 2021): 011–20. http://dx.doi.org/10.37871/jbres1180.
Texto completoZaineb, Tayyaba, Bushra Uzair, Waleed Y. Rizg, Waleed S. Alharbi, Hala M. Alkhalidi, Khaled M. Hosny, Barkat Ali Khan, Asma Bano, Mohammed Alissa y Nazia Jamil. "Synthesis and Characterization of Calcium Alginate-Based Microspheres Entrapped with TiO2 Nanoparticles and Cinnamon Essential Oil Targeting Clinical Staphylococcus aureus". Pharmaceutics 14, n.º 12 (9 de diciembre de 2022): 2764. http://dx.doi.org/10.3390/pharmaceutics14122764.
Texto completoAbdelhamid, Mohamed A. A., Mi-Ran Ki, Amer Ali Abd Abd El-Hafeez, Ryeo Gang Son y Seung Pil Pack. "Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects". Pharmaceutics 15, n.º 1 (3 de enero de 2023): 168. http://dx.doi.org/10.3390/pharmaceutics15010168.
Texto completoAhmed, Faraidun A., Khadijakhalil M. Barzani y Payman A. Hamasaeed. "Antibacterial and Wound Healing Assessment of Silver Nanoparticles against Multidrug-Resistant Klebsiella variicola". Cihan University-Erbil Scientific Journal 8, n.º 2 (20 de agosto de 2024): 49–55. http://dx.doi.org/10.24086/cuesj.v8n2y2024.pp49-55.
Texto completoChidambaram, Moorthi, R. Manavalan y K. Kathiresan. "Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations". Journal of Pharmacy & Pharmaceutical Sciences 14, n.º 1 (16 de febrero de 2011): 67. http://dx.doi.org/10.18433/j30c7d.
Texto completoTesis sobre el tema "Multidrug nanoparticles"
Trần, Natalie Lan Linh. "Innovative multidrug nanomedicines for the treatment of myocardial ischemia/ reperfusion injuries". Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASQ073.
Texto completoMyocardial ischemia/ reperfusion is a complex pathological condition involving various signaling mechanisms. Due to their interactions, available treatments for reperfusion injuries often prove insufficient. It is crucial to explore approaches that integrate multiple agents targeting different biological pathways. While nanomedicine offers opportunities to protect active ingredients and optimize therapeutic targeting, it faces challenges like low drug incorporation rates. The squalenoylation method holds potential to address these issues. We first studied squalene-based NPs containing cyclosporine A (SqCsA) in vitro, assessing their toxicity and cardioprotective capacity. We then tested squalene-adenosine formulations (SQAd) in an in vivo mouse model, observing beneficial effects on cardiac function, though statistical significance was not reached. Subsequently, we developed SQAd/Vit E nanoparticles and tested them in an optimized rat model of myocardial ischemia-reperfusion, applying comprehensive analysis methods and captured detailed cardioprotective effects. Finally, we investigated protein corona formation on these nanoparticles to shed light on their in vivo behavior in biological fluids. These findings highlight the potential of novel nanomedical formulations in treating cardiac I/R injuries
Vlerken, Lilian Emilia van. "Modulation of multidrug resistance in cancer using polymer-blend nanoparticles : thesis /". Diss., View dissertation online, 2008. http://hdl.handle.net/2047/d10017355.
Texto completoTaute, C. J. F. "Tumour specific targeted in vitro theranostics application of fabricated nanostructures in a multi-drug resistant ovarian carcinoma cell line". Thesis, University of the Western Cape, 2013. http://hdl.handle.net/11394/4530.
Texto completoOvarian cancer is called the “Silent Killer” as it is often diagnosed in advanced stages of the disease or misdiagnosed which ends with a poor prognostic outcome for the patient. A high rate of disease relapse, a high incidence-to-mortality ratio as well as acquired multidrug resistance makes it necessary to find alternative diagnostic- and therapeutic tools for ovarian cancer. Nanotechnology describes molecular devices with at least one dimension in the sub- 1μm scale and has been suggested as a possible solution for overcoming challenges in cancer multidrug resistance as well as early diagnosis of the disease. One-pot synthesized gold nanoparticles were used to demonstrate in vitro drug delivery of doxorubicin in a manner which overcame the cytoprotective mechanisms of a multidrug resistant ovarian carcinoma cell line (A2780cis) by inducing apoptosis mediated by caspase-3 within 3h of treatment. The gold nanoparticles were further functionalized with nitrilotriacetic acid and displayed specific interaction with a 6xHis-tagged cancer targeting peptide, chlorotoxin. Proprietary indium based quantum dots were functionalized with the same surface chemistry used for gold nanoparticles and bioconjugated with chlorotoxin. Wide field fluorescence studies showed the peptide-quantum dot construct specifically targeted enhanced green fluorescent tagged matrix metalloproteinase-2 transfected A2780cis cells in a specific manner. The cytoprotective multidrug resistant mechanisms of the ovarian carcinoma was overcome successfully with a single dose of doxorubicin loaded gold nanoparticles and tumour specific targeting was demonstrated using quantum dots with a similar surface chemistry used for the gold nanoparticles.
Sen, Gulseren Petek. "Fabrication Of Poly (dl-lactic-co-glycolic Acid) Nanoparticles And Synthetic Peptide Drug Conjugate For Anti-cancer Drug Delivery". Master's thesis, METU, 2010. http://etd.lib.metu.edu.tr/upload/12611405/index.pdf.
Texto completoWan, Chung Ping Leon. "The effect of P-glycoprotein inhibition and ultrasound exposure on the cytotoxicity of taxane loaded diblock copolymer nanoparticles in multidrug resistant cells". Thesis, University of British Columbia, 2014. http://hdl.handle.net/2429/49957.
Texto completoPharmaceutical Sciences, Faculty of
Graduate
Ngema, Xolani Terrance. "Metallic nanoparticles with polymeric shell: A multifunctional platform for application to biosensor". University of the Western Cape, 2018. http://hdl.handle.net/11394/6330.
Texto completoTuberculosis (TB) is an airborne disease caused by Mycobacterium tuberculosis (MTB) that usually affects the lungs leading to severe coughing, fever and chest pains. It was estimated that over 9.6 million people worldwide developed TB and 1.5 million died from the infectious disease of which 12 % were co-infected with human immunodeficiency virus (HIV) in the year 2015. In 2016 the statistics increased to a total of 1.7 million people reportedly died from TB with an estimated 10.4 million new cases of TB diagnosed worldwide. The development of the efficient point-of-care systems that are ultra-sensitive, cheap and readily available is essential in order to address and control the spread of the tuberculosis (TB) disease and multidrugresistant tuberculosis.
Dormont, Flavio. "Development of nanomedicines for inflammation disorders : evaluation of pharmacological efficacy on preclinical models Nanomedicines for the management of Sepsis Nanoplumbers: Biomaterials to fight cardiovascular diseases Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation Translation of Nanomedicines from Lab to Industrial Scale Synthesis: The Case of Squalene-Adenosine Nanoparticles". Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS451.
Texto completoAdvances in drug delivery have led to the development of many tools that help tailor the drug delivery strategy. In particular, “nanomedicines” have made it possible to obtain numerous innovations in oncology and diagnostic technology. By improving drug targeting and protecting the pharmaceutical agent from early metabolism, nanomedicines improve the therapeutic index of certain molecules, resulting in improved patient prognosis. However, with these promises come notable limitations, such as the low drug loading rate of certain nanoformulations, complicated industrial development or poor release control. Squalene-based nanoparticles have been developed to meet these limitations. Another advantage of squalene-based nanoparticles is that they make it possible to encapsulate several therapeutic agents within the same system, thus allowing multi-drug treatments.This is an important tool in the context of an excessive inflammatory response, where many factors often converge to advance the disease. Therefore, one of the objectives of this thesis was to develop and test on preclinical models of inflammation, squalene-based nanoparticles encapsulating two therapeutic agents: adenosine, as an endogenous mediator of inflammatory responses and an antioxidant as an inhibitor of oxidative stress. Our hypothesis is that a multi-drug therapy could be advantageous to counter the many pathogenic processes which reinforce each other during inflammatory responses, but also that a formulation in the form of nanoparticles could provide interesting targeting properties. During the work of this thesis, we also have the feasibility of industrial translation of the synthesis of squalene-based bioconjugates
Carrasco, Letícia Dias de Melo. "Arrranjos supramoleculares de lípide catiônico, antibióticos e polímeros: preparação, caracterização e atividade contra bactérias multirresistentes e micobactérias de crescimento rápido". Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/9/9136/tde-04082016-092804/.
Texto completoSupramolecular assemblies combining cationic lipid dioctadecyldimethylammonium bromide (DOD) and polymers, such as sodium carboxymethylcellulose (CMC) and poly(diallyldimethylammonium chloride) (PDDA), were prepared as nanoparticles (NPs), in the absence or presence of traditional antibiotic, such as clarithromycin (CLA). NPs prepared by electrostatic attraction between DOD bilayer fragments (BF), CMC and PDDA were evaluated against clinical strains of multidrug resistant (MDR) microorganisms, such as Pseudomonas aeruginosa MDR, Klebsiella pneumoniae producer of KPC carbapenemase enzyme, methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans fluconazole resistant, by plating and colony forming unities counting. DOD BF/CMC/PDDA NPs display high and broad-spectrum activity against MDR microrganisms, and PDDA is the excellent biocidal component in the NPs. The mechanism of antimicrobial action shows that NPs disassembly in the presence of microrganisms, with biopolymers withdrawn from the cell wall, as observed by scanning electron microscopy, consecutively lysing bacterial membrane as determined from the leakage of inner phosphorylated compounds. In this work there have also been developed NPs, based on lipid and polymers, as carriers for CLA. Ethanolic solution co-solubilizing CLA/DOD was injected in CMC aqueous solution, yielding colloidaly stable and anionic NPs, that were further added of PDDA solution, yielding stable and cationic NPs. CLA/DOD/CMC NPs and CLA/DOD/CMC/PDDA NPs incorporated CLA at doses high enough to inhibit M. abscessus growth inside macrophages or in biofilms. Larger CLA doses were toxic to macrophages while lower CLA doses reduced toxicity to macrophages despite their high antimicrobial activity. Cationic CLA NPs exhibited substantial toxicity against macrophages at the PDDA concentrations tested. The particulate nature of these CLA NPs possibly increases intracellular CLA retention in comparison to free CLA, probably extending CLA activity against intracellular pathogens. In conclusion, supramolecular assemblies combining cationic lipid and polymers, with or without traditional antibiotics, may find multiple possibilities of applications at pharmaceutical, medical, food and biotecnological fields.
Dreaden, Erik Christopher. "Chemistry, photophysics, and biomedical applications of gold nanotechnologies". Diss., Georgia Institute of Technology, 2012. http://hdl.handle.net/1853/51320.
Texto completoHsiao, Jui-Pin y 蕭睿彬. "Development of nanoparticles with chemotherapeutic/siRNA dual functions against multidrug-resistant cancer cells". Thesis, 2010. http://ndltd.ncl.edu.tw/handle/20319311035879470789.
Texto completo臺灣大學
醫學工程學研究所
98
To realize gene therapy and chemotherapy in multi-drug-resistant cancer cell, we develop carriers which can co-delivery gene and chemotherapy drug. The mPEG-PCL-PEI (M510i) tri-block polymers were synthesized by use mMPEG-PCL copolymer modified to PEI. The characteristic of these tri-block polymers were evaluated by 1H nuclear magnetic resonance and gel permeation chromatography. The critical micelle concentration (CMC) of micelle was evaluated by using pyrene as fluorescence probe. The particle size, zeta potential, and morphology of micelle was studied by dynamic light scattering and transmission electron microscopy. The results indicate that the paclitaxel loaded micelles and DNA complexes with micelles were 226 nm and 238 nm. The gene transfection efficiency was evaluated by used flow cytometry to evaluate green fluorescence protein (GFP) expression. The gene transfection efficiency performed better than PEI 25K in MCF-7 ADR cell. In siRNA experiments, we can transfect MDR-1 siRNA to silence P-glycoprotein expression 50%. In viro cytotoxicity, dual agent micelle of were tested of MCF-7 wt and MCF-7 ADR by MTT assy. These results suggested the PEG-PCL-PEI tri-block polymer as potential carriers for gene therapy and chemotherapy.
Libros sobre el tema "Multidrug nanoparticles"
Banu, Afreen, Vandana Rathod y E. Ranganath. Synthesis and Characterization of Silver Nanoparticles by Rhizopus Stolonifer and Its Activity Against Multidrug Resistant Escherichia Coli and S. GRIN Verlag GmbH, 2012.
Buscar texto completoWong, Ho-Lun. A study of nanoparticle drug carrier for treatment of multidrug-resistant breast cancer with loco-regional involvement. 2006.
Buscar texto completoCapítulos de libros sobre el tema "Multidrug nanoparticles"
Palaskar, Rutuja S., Darshana S. Dhokane y Balaprasad G. Ankamwar. "Green-Synthesized Nanoparticles to Combat Multidrug-Resistant Bacteria". En Nanotechnology Based Strategies for Combating Antimicrobial Resistance, 511–32. Singapore: Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-97-2023-1_19.
Texto completoChandrasekaran, Aiswarya y G. H. R. Eranga Karunaratne. "Use of Nanoparticles in Multidrug Resistant Tuberculosis Diagnosis". En Nanotechnology for Infectious Diseases, 371–86. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9190-4_17.
Texto completoHossain, Md Monir, Shakil Ahmed Polash, Tanushree Saha y Satya Ranjan Sarker. "Gold Nanoparticles: A Lethal Nanoweapon Against Multidrug-Resistant Bacteria". En Nanotechnology in the Life Sciences, 311–51. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-10220-2_9.
Texto completoUddin, Imran, Divya S. Parimi, Tarun K. Bollu, Chandra S. Bhatt y Anil K. Suresh. "Silver Nanoparticles as Potent Multidrug-Resistant Incorporants in Biomedicine". En Emerging Modalities in Mitigation of Antimicrobial Resistance, 475–88. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-84126-3_21.
Texto completoTian, Sichao, Peiyan Yuan y Qing-Hua Xu. "Metal Nanoparticles As Alternative Antimicrobial Agents to Combat Multidrug Resistance Bacteria". En Nanotechnology Based Strategies for Combating Antimicrobial Resistance, 81–115. Singapore: Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-97-2023-1_4.
Texto completoBharadwaj, Kaushik Kumar, Bijuli Rabha, Bhabesh Kumar Choudhury, Aditi Das, Lydia Islary, Dorothy Bhattacharjya, Monoswi Chakraborty, Debabrat Baishya y Arabinda Ghosh. "Role of Gold Nanoparticles Against Multidrug Resistance (MDR) Bacteria: An Emerging Therapeutic Revolution". En Emerging Modalities in Mitigation of Antimicrobial Resistance, 489–511. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-84126-3_22.
Texto completoAhmed, Abeer Ahmed Qaed, Lin Xiao, Tracey Jill Morton McKay y Guang Yang. "Green Metal-Based Nanoparticles Synthesized Using Medicinal Plants and Plant Phytochemicals against Multidrug-Resistant Staphylococcus aureus". En Green Synthesis in Nanomedicine and Human Health, 181–246. First edition. | Boca Raton, FL : CRC Press, [2021]: CRC Press, 2021. http://dx.doi.org/10.1201/9781003023197-15.
Texto completoParmar, Ankush y Shweta Sharma. "Nanoparticles: A Potential Breakthrough in Counteracting Multidrug-Resistant Bacterial Infections—A Holistic View on Underlying Mechanisms and Antibacterial Properties". En Biomedical Translational Research, 153–77. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9232-1_11.
Texto completoPinky, Nirantak Kumar y Ankita Sharma. "Synergic Effects of Nanoparticles with other Drugs and Their Combined Effects". En Plant Mediated Synthesis of Metal Nanoparticles, 109–28. BENTHAM SCIENCE PUBLISHERS, 2024. http://dx.doi.org/10.2174/9789815256352124010007.
Texto completoBisht, Shiwali y Lovely Tyagi. "ADVANCES IN NANOTECHNOLOGY FOR CREATING ANTIBACTERIAL DRUGS". En Futuristic Trends in Biotechnology Volume 3 Book 13, 241–50. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3bjbt13p2ch7.
Texto completoActas de conferencias sobre el tema "Multidrug nanoparticles"
Sabir, Dana. "SYNERGISTIC EFFECT OF SILVER NANOPARTICLES COMBINED WITH DIFFERENT ANTIBIOTICS AGAINST MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII STRAIN H72721". En International Conference of Natural Science. Presidency of Charmo University, 2018. http://dx.doi.org/10.31530/17028.
Texto completoYuvasree, P., K. Nithya y N. Neelakandeswari. "Biosynthesis of silver nanoparticles from Aloe vera plant extract and its antimicrobial activity against multidrug resistant pathogens". En International Conference on Advanced Nanomaterials & Emerging Engineering Technologies (ICANMEET-2013). IEEE, 2013. http://dx.doi.org/10.1109/icanmeet.2013.6609241.
Texto completoWang, Xu, Jun Li, Yuxiang Wang, Lydia Koenig, Ada Gjyrezi, Paraskevi Giannakakou, Edwin H. Shin et al. "Abstract LB-196: A folate receptor-targeted nanoparticle minimizes multidrug resistance in human cancer xenograft model". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-lb-196.
Texto completo